4
Changes in Ownership
Entrada Therapeutics, Inc. Filed Acc 0001689375-24-000041
Chief Scientific Officer sold 1,238 shares at $18.00 ($22,284)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Sethuraman Natarajan Chief Scientific Officer | 2024-07-12 | Sale 10b5-1 | −600 | $18.00 | $10,800 | 189,452 | D |
| Sethuraman Natarajan Chief Scientific Officer | 2024-07-15 | Sale 10b5-1 | −638 | $18.00 | $11,484 | 188,814 | D |
| Open-market sales · 1,238 sh · avg $18.00 · $22,284 | |||||||
Loading xslF345X05/wk-form4_1721162618.xml…